Bennett Associates Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Sell
3,342
-190
-5% -$15.3K 0.16% 49
2026
Q1
$306K Sell
3,532
-12
-0.3% -$1.15K 0.21% 46
2025
Q4
$340K Sell
3,544
-223
-6% -$21.7K 0.24% 41
2025
Q3
$359K Buy
3,767
+379
+11% +$34.8K 0.26% 37
2025
Q2
$295K Buy
+3,388
New +$287K 0.23% 43
2025
Q1
Sell
-3,959
Closed -$316K 47
2024
Q4
$316K Sell
3,959
-256
-6% -$22.2K 0.26% 39
2024
Q3
$379K Buy
4,215
+205
+5% +$17.2K 0.31% 33
2024
Q2
$316K Sell
4,010
-36
-0.9% -$2.95K 0.28% 35
2024
Q1
$353K Sell
4,046
-537
-12% -$45.8K 0.32% 34
2023
Q4
$378K Buy
+4,583
New +$349K 0.37% 34

Other funds holding MDT

Bennett Associates Wealth Management's MDT Position: Q2 2026 in Review

Bennett Associates Wealth Management reduced its Medtronic (MDT) stake by 5.4% in Q2 2026, selling an estimated $15.3K and leaving 3,342 shares worth $261K. The position accounts for 0.16% of the portfolio, ranked #49.

Bennett Associates Wealth Management first reported a position in MDT in Q4 2023 and has held it in 10 quarters since. The position peaked at $379K in Q3 2024. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Bennett Associates Wealth Management held 3,342 shares of Medtronic worth $261K as of Q2 2026.
  • Bennett Associates Wealth Management sold 190 Medtronic shares in Q2 2026, an estimated $15.3K.
  • Medtronic made up 0.16% of Bennett Associates Wealth Management's portfolio in Q2 2026, its #49 holding.
  • Bennett Associates Wealth Management first reported a position in Medtronic in Q4 2023 and has held it in 10 quarters since.
  • Bennett Associates Wealth Management's Medtronic position peaked at $379K in Q3 2024.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Bennett Associates Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.